Subsequent to fulfilment of the Conditions Precedent under the BTA the transactions has been consummated with effect from today i.e. October 01, 2026.
Closure of Trading window for the quarter and six months ended September 30, 2026.
Press Release on Acquisition of Wellness Portfolio of Group pharmaceuticals Limited
Acquisition of the Wellness Portfolio of Group Pharmaceuticals Limited.
Voting Result and scrutinizer Report of 47th Annual General Meeting.
Updates on Acquisition of Aequitas Healthcare Private Limited.
Allotment of 94,000 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022.
Updates on Acquisition of Aequitas Healthcare Private Limited
Press Release on acquisition of Aequitas Healthcare Private Limited.
Acquisition of Aequitas Healthcare Private Limited
press release relating to appointment of Mr. Anil Kumar Matai (DIN: 03122685) as an additional director in the category of Non-Executive Independent Director.
press release relating to appointment of Mr. Anil Kumar Matai (DIN: 03122685) as an additional director in the category of Non-Executive Independent Director.
Appointment of Mr. Anil Kumar Matai (DIN: 03122685) as an Additional Director in the category of Non-Executive Independent Director.
Appointment of Mr. Anil Kumar Matai (DIN: 03122685) as an Additional Director in the category of Non-Executive Independent Director.
Appointment of Mr. Anil Kumar Matai (DIN: 03122865) as an Additional Director in the category of Non-Executive Independent Director.
Appointment of Mr. Anil Kumar Matai (DIN: 03122865) as an Additional Director in the category of Non-Executive Independent Director.